Aspen Neuroscience, a pioneering force in regenerative medicine, has received clearance from the U.S. FDA for its Investigational New Drug (IND) application for ANPD001. ANPD001 is a novel autologous (“self-derived”) cell therapy that has the potential to treat Parkinson’s Disease by replenishing lost dopamine neurons. This green light from the FDA propels Aspen Neuroscience into historic territory, initiating a clinical trial for ANPD001 in human patients. [Read more…]
Stem Cell Market Intelligence – “Make Smarter Decisions, Faster”
Stem cell market intelligence is defined as data relevant to the stem cell industry, gathered for the purpose of making informed business decisions. Business activities that market intelligence may support include:
- New product development
- Sales strategy
- Market strategy
- New client acquisition
Cord Blood and Tissue Banking: 14 Terms to Define
Since the first stem cell transplant occurred more than 65 years ago (1957), there has been a nearly exponential increase in stem cell transplants, and in late 2012, the millionth stem cell transplant occurred, a landmark event in stem cell medicine. It is clear that the stem cells contained within cord blood banking now have the potential to improve and save lives. Since the first cord blood transplant was performed in 1988, stem cells derived from umbilical blood have been used in more than 40,000 transplants worldwide. [Read more…]
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic
TAMPA, FL – EV Biologics Corp, OTC PINK:YECO, announced that it has completed production of a next-generation, “Gen-2”, MSC exosome-based therapeutic product.
Rigorous product analysis has already begun, and the Company has engaged leading independent testing laboratories to perform sophisticated analyses of molecular composition, therapeutic activity, and any potential forms of contamination, to thoroughly validate the product and prepare comprehensive product data specifications that are second to none. [Read more…]
New Study Reveals Breakthrough in Epidermal Regeneration Using Mesenchymal Stem Cell Extracellular Vesicles and Ronawk’s Bio-Blocks™
Overland Park, KS – In a groundbreaking development, a recent peer-reviewed paper titled “Mesenchymal Stem Cell Extracellular Vesicles from Tissue-Mimetic System Enhance Epidermal Regeneration via Formation of Migratory Cell Sheets,” published on July 29, 2023, in the journal “Tissue Engineering and Regenerative Medicine,” offers open access to its findings. [Read more…]
- « Previous Page
- 1
- …
- 116
- 117
- 118
- 119
- 120
- …
- 336
- Next Page »